natgillin/translations-raw huggingface dataset:
1 The dose may be escalated to 15 mg once daily after 2 cycles if patient is not responding to treatment and is tolerating the treatment.
1 Če se bolnik ne odziva na zdravljenje in ga dobro prenaša, se lahko odmerek po dveh ciklih zveča na 15 mg enkrat na dan.
1 The overall response was assessed by an Independent Response Committee using the 1996 NCI-WG
1 Celotni odziv je ocenil neodvisni Odbor za oceno na podlagi smernic NCI-WG (National
1 The overall response was assessed by an Independent Response Committee using the 1996 NCI-WG
1 Celotni odziv je ocenil neodvisni Odbor za oceno na podlagi smernic NCI-WG (National Cancer
1 This adverse reaction was not observed in the Phase 3 clinical studies for Stribild but identified from clinical studies or post-marketing experience for tenofovir disoproxil fumarate when used with other antiretrovirals.
1 Tega neželenega učinka niso opazili v kliničnih študijah faze 3 za zdravilo Stribild, temveč je bil opredeljen v kliničnih študijah ali izkušnjah v obdobju trženja za dizoproksiltenofovirijev fumarat pri uporabi z drugimi protiretrovirusnimi zdravili.
1 This side effect has been observed in post-marketing experience.
1Neželeni učinek je bil opisan po začetku trženja zdravila.
1 This study was conducted using the fixed-dose combination tablet elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil.
1 Ta študija je bila izvedena s tabletami s fiksno kombinacijo elvitegravirja/kobicistata/emtricitabina/dizoproksiltenofovirata.
1 Through data cut-off (October 12, 2012), with median duration of Soliris therapy of 44 weeks (range: 1dose to 88 weeks).
1 Ob koncu zbiranja podatkov (12. oktober 2012), mediano trajanje zdravljenja s Solirisom je bilo 44 tednov (razpon: 1 odmerek do 88 tednov).
1 Through data cut-off (September 4, 2012), with median duration of Soliris therapy of 50 weeks (range: 13 weeks to 86 weeks).
1 Do zaključka zbiranja podatkov (4. septembra 2012) z medianim trajanjem zdravljenja z zdravilom Soliris 50 tednov (razpon: 13 tednov do 86 tednov).
1 Thu.
1 Čet.
1 to 2 implantation matrices.
1 do 2 matriksa za implantacijo.
1 to 3 minutes before the injection of Ceplene.
1 do 3 minute pred injiciranjem zdravila Ceplene.
1 to 3 ml
1 do 3 ml
1 to < 6 months
1 do < 6 mesecev
1 Total daily dose of linagliptin is equal to 5 mg
1 Dnevni odmerek linagliptina je 5 mg.
1 transdermal patch of 10 cm2 contains 18 mg rivastigmine and delivers 9.5 mg/24 h.
1 transdermalni obliž velikosti 10 cm2 vsebuje 18 mg rivastigmina in sprosti 9,5 mg/24 h.
1 transdermal patch of 15 cm2 contains 27 mg rivastigmine and delivers 13.3 mg/24 h.
1 transdermalni obliž velikosti 15 cm2 vsebuje 27 mg rivastigmina in sprosti 13,3 mg/24 h.
1 transdermal patch of 4.15 cm2 contains 7.17 mg rivastigmine and delivers 4.6 mg/24 h.
1 transdermalni obliž velikosti 4,15 cm2 vsebuje 7,17 mg rivastigmina in sprosti 4,6 mg/24 h.
1 transdermal patch of 5 cm2 contains 9 mg rivastigmine and delivers 4.6 mg/24 h.
1 transdermalni obliž velikosti 5 cm2 vsebuje 9 mg rivastigmina in sprosti 4,6 mg/24 h.
1 transdermal patch of 8.3 cm2 contains 14.33 mg rivastigmine and delivers 9.5 mg/24 h.
1 transdermalni obliž velikosti 8,3 cm2 vsebuje 14,33 mg rivastigmina in sprosti 9,5 mg/24 h.
1 transdermal patch per pouch.
1 transdermalni obliž na vrečko
1 transfer device
1 pribor za prenos vehikla
1 transfer device for reconstitution
1 pripomoček za prenos za rekonstitucijo
1 trocar
1 trokar
1 Tue.
1 Tor.
1 Twice daily regimen ± metformin ± pioglitazone ± DPP-4 inhibitor 2 Twice daily regimen ± metformin
1 Shema dvakrat na dan ± metformin ± pioglitazon ± zaviralec DPP-4 2 Shema dvakrat na dan ± metformin
1 unit insulin detemir corresponds to 1 international unit of human insulin.
Ena enota insulina detemir ustreza eni mednarodni enoti humanega insulina.
1 Upper respiratory tract infection includes the following preferred terms: nasopharyngitis, influenza, upper respiratory tract infection, pharyngitis, rhinitis, sinusitis, pharyngitis bacterial, tonsillitis, acute tonsillitis, laryngitis, viral pharyngitis, and viral upper respiratory tract infection.
1 Okužba zgornjih dihal vključuje naslednje prednostne izraze: nazofaringitis, gripa, okužba zgornjih dihal, faringitis, rinitis, sinuzitis, bakterijski faringitis, tonzilitis, akutni tonzilitis, laringitis, virusni faringitis in virusna okužba zgornjih dihal
1 Values expressed as geometric means.
1 Vrednosti so izražene kot geometrične sredine.
1 Vasovagal reactions and hypersensitivity reactions related to Visudyne infusion have been reported.
1 Poročali so o vazovagalnih reakcijah in preobčutljivostnih reakcijah na infuzijo zdravila Visudyne.
1 venipuncture set
1 setti til bláæðarástungu
1 vented transfer device for reconstitution 1 filter
1 prezračevan pripomoček za prenos za rekonstitucijo 1 filter
1 vial
1 stekl
1 vial
1 steklenička
1 vial
1 viale
1 vial
10 vial
1 vial
EU/1/97/030/013
1 vial
EU/1/97/030/028
1 vial
EU/1/97/030/168
1 vial
EU/1/97/030/200
1 vial
i.e./2,5 ml
1 vial
i.e./3 ml
1 vial
uporabo
1 vial
viala
1 vial (10 ml)
1 viala (10 ml)
1 vial (12 ml) with solvent for reconstitution or
1 vialo (12 ml) s topilom za pripravo raztopine ali
1 vial (12 ml) with white powder for solution for injection
1 vialo (12 ml) z belim praškom za raztopino za injiciranje,
1 vial (1560 IU/5ml)
1 viala (1560 i.e./5 ml)
1 vial (17 ml)
1 viala (17 ml)
1 vial (2 ml) with solvent for reconstitution or
1 vialo (2 ml) s topilom za pripravo raztopine ali
1 vial (2 ml) with white powder for solution for injection
1 vialo (2 ml) z belim praškom za raztopino za injiciranje,
1 vial (2.5 g/25 ml, 5 g/50 ml, 10 g/100 ml, 20 g/200 ml or 40 g/400 ml),
1 viala (2,5 g/25 ml, 5 g/50 ml, 10 g/100 ml, 20 g/200 ml ali 40 g/400 ml),
1 vial (4 mg/0.1 ml) 18G filter needle
1 viala (4 mg/0,1 ml) filtrirna igla 18 G
1 vial (powder) + 1 pre- filled syringe (solvent)
1 viala (prašek) + 1 napolnjena injekcijska brizga (vehikel)
1 vial +
1 viala +
1 vial +
injiciranje
1 vial +
uporaba
1 vial + 1
1 viala + 1 ampula
1 vial + 1
1 viala + 1 vložek
1 vial + 1 adapter
1 viala + 1 adapter
1 vial + 1 ampoule
1 ampula
1 vial + 1 ampoule
1 viala +
1 vial + 1 ampoule
1 viala + 1 ampula + 1
1 vial + 1 ampoule + 1 injection set1
1 viala + 1 ampula + 1 injekcijski set1
1 vial + 1 injection set2
1 viala + 1 injekcijski set2
1 vial + 1 injection syringe + 1 injection needle + 1 cleansing swab
1 viala + 1 injekcijska
1 vial + 1 pre-
1 viala + 1
1 vial + 1 pre- filled syringe + 1 injection set
1 viala + 1 napolnjena injekcijska brizga + 1 komplet za injiciranje 1 viala + 1
1 vial + 1 pre- filled syringe + 1 injection set
napolnjena injekcijska brizga + 1 komplet za injiciranje
1 vial + 1 pre- filled syringe + 1 injection set
napolnjena injekcijska brizga + 1 komplet za injiciranje 1 viala + 1
1 vial + 1 pre-filled
1 viala + 1 napolnjena
1 vial + 1 pre-filled syringe
1 napolnjena brizga + 1 adapter za vialo
1 vial + 1 pre-filled syringe
injekcijskih
1 vial + 1 pre-filled syringe + 1 'MiniSpike' rec. device
+ 1 napolnjena injekcijska brizga
1 vial + 1 pre-filled syringe + 2
1 viala +1 napolnjena brizga + 2
1 vial + 1 vial
1 viala +
1 vial + 1 vial
1 viala + 1
1 vial + 1 vial
1 viala +1 viala
1 vial + 1 vial
1 viala+ 1 viala
1 vial + 1 vial
EU/1/10/662/002
1 vial + 1 vial + 1 syringe with pre-attached safety needle +3 safety needles
pritrjeno varnostno iglo + 3 varnostne igle
1 vial + 6 injection
1 viala + 6 injekcijskih
1 vial + 6 injection syringes + 6 injection needles + 12 cleansing swabs
brizg + 6 injekcijskih igel
1 vial + 6 injection syringes with attached needle + 12 cleansing swabs
1 viala + 6 injekcijskih
1 vial +1 vial
1 viala +1 viala
1 vial +50ml infusion bag
1 viala +
1 vial 0.5 g 1 vial 1 g vial 2 g
1 viala 0,5 g 1 viala 1 g 1 viala 2 g
1 vial 100 mg 2 vials 100 mg 3 vials 100 mg 4 vials 100 mg 5 vials 100 mg
1 viala 100 mg 2 viali 100 mg 3 viale 100 mg 4 viale 100 mg 5 vial 100 mg
1 vial 100mg 2 vials 100 mg 3 vials 100 mg 4 vials 100 mg 5 vials 100 mg
1 viala 100 mg 2 viali 100 mg 3 viale 100 mg 4 viale 100 mg 5 vial 100 mg
1 vial 2 vials
1 viala 2 viali
1 vial 250 IU powder
1 viala z 250 i.e., prašek
1 vial 3 vials
1 viala 3 viale
1 vial 500 IU powder
1 viala s 500 i.e., prašek
1 vial = 2.3 mg ranibizumab.
1 viala = 2,3 mg ranibizumaba.
1 vial adapter
1 adapter za vialo
1 Vial adapter
1 nastavek za vialo
1 vial adapter
1 nastavek za vialo,
1 vial adapter
1 nastavek za vialo.
1 vial adapter
1 vmesnik za vialo
1 vial adapter + 1 needle + 1 syringe + 4 alcohol pads)
+ 1 nastavek za vialo + 1 igla + 1 brizga + 4 sterilni zloženci)
1 vial adapter with a pre-attached needle,
1 adapter za vialo z iglo,
1 VIAL AND 1 PRE-FILLED SYRINGE WITH 2 NEEDLES
1 VIALA IN 1 NAPOLNJENA INJEKCIJSKA BRIZGA Z 2 IGLAMA
1 vial and 1 vial
1 viala in 1 viala
1 vial and 50 µl pump
1 viala razpršilnik za 50 µl
1 vial containing 0.5 mL 5 vials each containing 0.5 mL 10 vials each containing 0.5 mL
1 viala z 0,5 ml raztopine 5 vial po 0,5 ml raztopine 10 vial po 0,5 ml raztopine
1 vial containing 25 mg lyophilized powder to be reconstituted with 5 ml sodium chloride 9 mg/ml (0.9%) solution for injection
1 viala s 25 mg liofiliziranega praška za rekonstitucijo s 5 ml 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje.
1 vial containing 40 mg adalimumab
1 viala s 40 mg adalimumaba
1 vial containing 40 mg adalimumab for paediatric use 1 sterile injection syringe
1 viala s 40 mg adalimumaba za pediatrično uporabo 1 sterilna injekcijska brizga
1 vial containing Pergoveris powder
1 viala s praškom zdravila Pergoveris
1 Vial containing the MenA Lyophilised Conjugate Component as a white to off-white powder
1 viala, ki vsebuje komponento liofiliziranega konjugata MenA kot bel do belkast prašek
1 Vial containing the MenCWY Liquid Conjugate Component as clear solution
1 viala, ki vsebuje komponento tekočega konjugata MenCWY kot bistro raztopino
1 vial containing water for injections (solvent)
1 viala z vodo za injekcije (vehikel)
1 vial contains
1 viala vsebuje
1 vial contains 0.5 mL follitropin beta corresponding to:
1 viala vsebuje 0,5 ml folitropina beta, ki ustreza:
1 vial contains 10 ml equivalent to 1000 IU
1 viala vsebuje 10 ml, kar ustreza 1000 i.e.
1 vial contains 11 micrograms r-hFSH and 3 micrograms r-hLH.
Ena viala vsebuje 11 mikrogramov r-hFSH in 3 mikrograme r-hLH.
1 vial contains 1400 mg/11.7 mL rituximab.
1 viala vsebuje 1400 mg/11,7 ml rituksimaba.
1 vial contains 1600 mg/13.4 mL rituximab.
1 viala vsebuje 1600 mg/13,4 ml rituksimaba.
1 vial contains 200 mg tocilizumab.
1 viala vsebuje 200 mg tocilizumaba.
1 vial contains 400 mg tocilizumab.
1 viala vsebuje 400 mg tocilizumaba.
1 vial contains 50,000 IU epoetin beta.
1 viala vsebuje 50.000 i.e. epoetina beta.
1 vial contains 80 mg tocilizumab.
1 viala vsebuje 80 mg tocilizumaba.
1 vial contains: Urea, sodium chloride, polysorbate 20, sodium dihydrogen phosphate, disodium hydrogen phosphate, calcium chloride, glycine, L-Leucine, L-Isoleucine, L-Threonine, L-Glutamic acid, and L-Phenylalanine.
1 viala vsebuje: sečnino, natrijev klorid, polisorbat 20, natrijev dihidrogenfosfat, natrijev hidrogenfosfat, kalcijev klorid, glicin, L-levcin, L-izolevcin, L-treonin, L-glutaminsko kislino in L- fenilalanin.
1 vial EU/1/96/022/017 Powder for solution for injection.
1 viala EU/1/96/022/017 Prašek za raztopino za injiciranje.
1 vial EU/1/96/022/017 – ZYPREXA - Powder for solution for injection.
1 viala EU/1/96/022/017 – ZYPREXA - Prašek za raztopino za injiciranje.
1 vial EU/1/96/027/003
1 viala EU/1/96/027/003
1 vial EU/1/96/027/005
1 viala EU/1/96/027/005
1 vial human normal immunoglobulin
1 viala humanega polispecifičnega imunoglobulina 2,5 g/25 ml
1 vial Myocet buffer
1 viala pufra Myocet
1 vial Myocet doxorubicin HCl 1 vial Myocet liposomes
1 viala Myocet doksorubicinijevega klorida 1 viala liposomov Myocet
1 vial of 0.23 ml solution for injection, 1 filter needle (18G x 1½″, 1.2 mm x 40 mm, 5 µm).
1 viala z 0,23 ml raztopine za injiciranje, 1 igla s filtrom (18G x 1½″, 1,2 mm x 40 mm, 5 µm)
1 vial of 0.23 ml solution for injection, 1 injection needle (30G x ½″, 0.3 mm x 13 mm), 1 filter needle (18G x 1½″, 1.2 mm x 40 mm, 5 µm), 1 syringe (1 ml).
1 viala z 0,23 ml raztopine za injiciranje, 1 injekcijska igla (30G x ½″, 0,3 mm x 13 mm), 1 igla s filtrom (18G x 1½″, 1,2 mm x 40 mm, 5 µm), 1 brizga (1 ml).
1 vial of 0.23 ml solution for injection.
1 viala z 0,23 ml raztopine za injiciranje.
1 vial of 0.3[0.45; 0.7; 1] ml
1 viala z 0,3[0,45; 0,7; 1] ml
1 vial of 1 dose (2 ml) 10 vials of 1 dose (2 ml) 20 vials of 1 dose (2 ml) 1 vial of 5 doses (10 ml)
1 viala z enim odmerkom (2 ml) 10 vial z enim odmerkom (2 ml) 20 vial z enim odmerkom (2 ml) 1 viala s 5 odmerki (10 ml)
1 vial of 1 ml solvent Pack size of 1
1 viala z 1 ml vehikla Velikost pakiranja po 1
1 vial of 1.3 mg powder
1 viala z 1,3 mg praška
1 vial of 1.5 mL solvent 4 vials of 10 mg powder 4 vials of 1.5 mL solvent
1 viale z 1,5 ml vehikla 4 viale z 10 mg praška 4 viale z 1,5 ml vehikla
1 vial of 1.5 mL solvent 4 vials of 20 mg powder 4 vials of 1.5 mL solvent
1 viale z 1,5 ml vehikla 4 viale z 20 mg praška 4 viale z 1,5 ml vehikla
1 vial of 10 doses and 1
1 viala z 10 odmerki in 1 stekleničko za rekonstitucijo
1 vial of 10 ml
1 viala 10 ml
1 vial of 10 ml
1 vialo z 10 ml
1 vial of 10 ml 5 vials of 10 ml
1 viala po 10 ml 5 vial po 10 ml
1 vial of 10 ml 5 vials of 10 ml
1 viala z 10 ml 5 vial z 10 ml
1 vial of 10 ml contains 1,000 international units
1 viala z 10 ml vsebuje 1.000 mednarodnih enot
1 vial of 10 ml contains 1,000 units
1 viala z 10 ml vsebuje 1.000 enot.
1 vial of 10 ml contains 400 international units
1 viala z 10 ml vsebuje 400 mednarodnih enot
1 vial of 100 doses and 1
1 viala s 100 odmerki in 1 stekleničko za rekonstitucijo
1 vial of 100 ml
1 viala 100 ml
1 vial of 2 ml 6 vials of 2 ml
viala z 2 ml 6 vial z 2 ml
1 vial of 20 mg powder
1 viala z 20 mg praška
1 vial of 20 ml contains 200 mg lacosamide
1 viala po 20 ml vsebuje 200 mg lakozamida.
1 vial of 3 ml 6 vials of 3 ml
1 viala s 3 ml 6 vial s 3 ml
1 vial of 30 ml with 250 mg telavancin
1 viala 30 ml z 250 mg telavancina
1 vial of 4 ml
1 viala s 4 ml
1 vial of 5 mg powder
1 viala s 5 mg praška
1 vial of 5 ml
1 viala (5 ml)
1 vial of 5 ml
5 vial s 5 ml
1 vial of 5 ml 4 vials of 5 ml 10 vials of 5 ml
Ena viala po 5 ml Štiri viale po 5 ml Deset vial po 5 ml
1 vial of 5 ml.
Ena viala po 5 ml.
1 vial of 50 doses and 1
1 viala s 50 odmerki in 1 stekleničko za rekonstitucijo
1 vial of 50 ml
1 vialo z 50 ml
1 vial of 50 ml with 750 mg telavancin
1 viala 50 ml s 750 mg telavancina
1 vial of Ceplene solution (0.5 mL)
1 vialo raztopine zdravila Ceplene (0,5 mL)
1 vial of concentrate for solution for infusion 6 vials of concentrate for solution for infusion 5 mg/5 ml
1 viala koncentrata za raztopino za infundiranje 6 vial koncentrata za raztopino za infundiranje 5 mg/5 ml
1 vial of concentrate for solution for infusion.
1 viala s koncentratom za raztopino za infundiranje.
1 vial of freeze- dried antigen and 1 vial of aqueous adjuvant
1 viala liofiliziranega antigena in 1 viala vodnega dodatka
1 vial of MEPACT (mifamurtide)
1 viala zdravila MEPACT (mifamurtid)
1 vial of powder (11 micrograms r-hFSH and 3 micrograms r-hLH).
1 viala s praškom (11 mikrogramov r-hFSH in 3 mikrogrami r-hLH).
1 vial of powder + 1 vial of solvent + 1 ml injection syringe + 1 safety needle + 2 vial adapters + 4 cleansing swabs.
1 viala s praškom + 1 viala z vehiklom + 1-mililitrska injekcijska brizga + 1 varnostna igla + 2 adapterja za vialo + 4 čistilne blazinice
1 vial of powder for solution for injection
1 viala praška za raztopino za injiciranje
1 vial of powder for solution for injection 1 vial water for injections 5 ml
1 viala praška za raztopino za injiciranje 1 viala vode za injekcije 5 ml
1 vial of powder for solution for injection and 1 ampoule of solvent for injection;
1 viala praška za raztopino za injiciranje in 1 ampula vehikla za injiciranje;
1 vial of powder for solution for injection and 1 ampoule of solvent for parenteral use;
1 viala s praškom za raztopino za injiciranje in 1 ampula z vehiklom za parenteralno uporabo,
1 vial of powder for solution for injection or infusion.
1 viala s praškom za raztopino za injiciranje ali infundiranje
1 vial of powder for solution for injection, 1 ampoule of solvent for injection, 1 injection syringe, 2 injection needles and 1 cleansing swab;
1 viala praška za raztopino za injiciranje, 1 ampula vehikla za injiciranje, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon;
1 vial of powder for solution for injection, 1 ampoule of solvent for parenteral use, 1 injection syringe, 2 injection needles and 1 cleansing swab;
1 viala s praškom za raztopino za injiciranje, 1 ampula z vehiklom za parenteralno uporabo, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon,
1 vial of powder for solution for injection.
1 viala s praškom za raztopino za injiciranje
1 vial of powder for solution for injection.
1 vialo praška za raztopino za injiciranje
1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab
1 viala s praškom, 1 ampula z vehiklom, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon
1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab 6 vials of powder and 6 ampoules of solvent
1 viala s praškom, 1 ampula z vehiklom, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon 6 vial s praškom in 6 ampul z vehiklom
1 vial of Rilonacept Regeneron powder
1 vialo praška zdravila Rilonacept Regeneron
1 vial of solvent
1 viala raztopila
1 vial of solvent
1 viala z vehiklom
1 vial of solvent
1 vialo s topilom.
1 vial of solvent (1 ml).
1 viala z vehiklom (1 ml).
1 vial of solvent contains 1 ml of water for injections.
Ena viala z vehiklom vsebuje 1 ml vode za injekcije.
1 vial of sterile water (solvent)
1 vialo sterilne vode (vehikla)
1 vial of suspension + 1 vial of emulsion corresponding to 10 ml of reconstituted product.
1 steklenička suspenzije + 1 steklenička emulzije, kar ustreza 10 ml rekonstituiranega cepiva
1 vial of suspension + 1 vial of emulsion corresponding to 50 ml of reconstituted product.
1 steklenička suspenzije + 1 steklenička emulzije, kar ustreza 50 ml rekonstituiranega cepiva
1 vial of suspension + 1 vial of emulsion: 25 dose size for gilts and sows, 100 dose size for piglets
1 steklenička suspenzije + 1 steklenička emulzije: 25 odmerkov za mladice in svinje, 100 odmerkov za pujske
1 vial of suspension + 1 vial of emulsion: 5 dose size for gilts and sows, 20 dose size for piglets
1 steklenička suspenzije + 1 stekleničko emulzije: 5 odmerkov za mladice in svinje, 20 odmerkov za pujske
1 vial of TAXOTERE 20 mg/0.5 ml concentrate for solution for infusion
1 viala zdravila TAXOTERE 20 mg/0,5 ml koncentrat za raztopino za infundiranje
1 vial of TAXOTERE 80 mg/2 ml concentrate for solution for infusion
1 viala zdravila TAXOTERE 80 mg/2 ml koncentrat za raztopino za infundiranje
1 vial per cardboard box
1 viala na zloženko
1 vial per pack.
1 viala v pakiranju.
1 vial Powder for solution for injection.
1 viala Prašek za raztopino za injiciranje.
1 vial recombinant human hyaluronidase
1 viala rekombinantne humane hialuronidaze 1,25 ml
1 vial Torisel 30 mg concentrate contains 474 mg ethanol (anhydrous)
Ena viala zdravila Torisel 30 mg koncentrat vsebuje 474 mg etanola (brezvodnega).
1 vial water for injections 10 ml
1 viala vode za injekcije 10 ml
1 vial with 10 ml water for injections
1 viala z 10 ml vode za injekcije
1 vial with 10 ml water for injections
1 vialo z 10 ml vode za injekcije
1 vial with 2.5 ml water for injections One device pack containing:
1 viala z 2,5 ml vode za injekcije Ena škatla s pripomočkom vsebuje: 1 priprava za prenos s filtrom 20/20
1 vial with 2.5 ml water for injections One device pack containing:
1 vialo z 2,5 ml vode za injekcije Ena škatla s pripomočkom vsebuje: 1 priprava za prenos s filtrom 20/20
1 vial with 2.5 mL water for injections.
1 hettuglas með 2,5 ml af vatni fyrir stungulyf.
1 vial with 20 ml water for injections
1 vialo z 20 ml vode za injekcije
1 vial with 250 IU nonacog alfa 1 vial with 500 IU nonacog alfa 1 vial with 1000 IU nonacog alfa 1 vial with 2000 IU nonacog alfa 1 vial with 3000 IU nonacog alfa
1 viala z 250 i.e. nonakoga alfa 1 viala s 500 i.e. nonakoga alfa 1 viala s 1.000 i.e. nonakoga alfa 1 viala z 2.000 i.e. nonakoga alfa 1 viala s 3.000 i.e. nonakoga alfa
1 vial with 5 ml water for injections
1 viala s 5 ml vode za injekcije
1 vial with 5 ml water for injections
1 vialo s 5 ml vode za injekcije
1 vial with 5 ml water for injections One device pack containing:
1 viala s 5 ml vode za injekcije Ena škatla s pripomočkom vsebuje:
1 vial with 5 ml water for injections One device pack containing:
1 vialo s 5 ml vode za injekcije Ena škatla s pripomočkom vsebuje:
1 vial with 5 mL water for injections.
1 hettuglas með 5 ml af vatni fyrir stungulyf.
1 vial with lyophilisate (50,000 IU) for solution for injection, 1 ampoule with preserved solvent (10 ml), 1 reconstitution and withdrawal device, 1 disposable syringe (10 ml), 1 needle (21G2)
1 viala z liofilizatom (50.000 i.e.) za raztopino za injiciranje, 1 ampula z vehiklom s konzervansoma (10 ml), 1 pripomoček za rekonstitucijo in odvzem, 1 injekcijska brizga (10 ml) za enkratno uporabo, 1 injekcijska igla (21G2)
1 vial with NovoEight powder
1 vialo s praškom zdravila NovoEight,
1 vial with NovoSeven powder
1 vialo s praškom NovoSeven,
1 vial with powder
1 vialo s praškom
1 vial with powder for solution for injection.
1 viala s praškom za raztopino za injiciranje.
1 vial with powder for solution for injection.
viala s praškom za raztopino za injiciranje
1 vial with powder, 1 pre-filled syringe with water for injections and 1 venipuncture set.
1 viala s praškom, 1 napolnjena injekcijska brizga z vodo za injekcije in 1 pribor za vensko punkcijo
1 vial with powder.
1 hettuglas með stungulyfsstofni.
1 vial with powder: 1000 IU albutrepenonacog alfa (400 IU/ml after reconstitution) 1 vial with 2.5 ml water for injections
1 viala z 2,5 ml vode za injekcije: 1000 i.e. albutrepenonakoga alfa (400 i.e./ml po rekonstituciji) Ena škatla s pripomočkom vsebuje:
1 vial with powder: 2000 IU albutrepenonacog alfa (400 IU/ml after reconstitution) 1 vial with 5 ml water for injections
1 viala s 5 ml vode za injekcije: 2000 i.e. albutrepenonakoga alfa (400 i.e./ml po rekonstituciji) Ena škatla s pripomočkom vsebuje:
1 vial with powder: 250 IU albutrepenonacog alfa (100 IU/ml after reconstitution) 1 vial with 2.5 ml water for injections
1 viala s praškom: 250 i.e. albutrepenonakoga alfa (100 i.e./ml po rekonstituciji) 1 viala z 2,5 ml vode za injekcije
1 vial with powder: 300 mcg (9.6 m IU) per vial.
1 viala s praškom: 300 mikrogramov (9,6 milijonov i.e.) na vialo.
1 vial with powder: 300 mcg (9.6 m IU) per vial.
1 viala s praškom: 300 mikrogramov (9,6 milijonov i.e.).
1 vial with powder: 500 IU albutrepenonacog alfa (200 IU/ml after reconstitution) 1 vial with 2.5 ml water for injections
1 viala s praškom: 500 i.e. albutrepenonakoga alfa (200 i.e./ml po rekonstituciji) 1 viala z 2,5 ml vode za injekcije
1 vial with solvent for reconstitution
1 vialo s topilom za pripravo raztopine.
1 vial with white powder for solution for injection
1 vialo z belim praškom za raztopino za injiciranje,
1 vial: 1000 IU moroctocog alfa (approx.
1 viala: 1.000 i.e. moroktokoga alfa (pribl.
1 vial: 1000 IU nonacog alfa (approx.
1 viala: 1.000 i.e. nonakoga alfa (pribl.
1 vial: 1000 IU nonacog gamma, approx.
1 viala: 1000 i.e. nonakoga gama, pribl.
1 vial: 1000 IU octocog alfa (400 IU/mL after reconstitution).
1 hettuglas: 1000 a.e. októkóg alfa (400 a.e./ml eftir blöndun).
1 vial: 1000 IU octocog alfa (400 IU/ml after reconstitution).
1 viala vsebuje 1000 i.e. oktokoga alfa (po rekonstituciji 400 i.e./ml).
1 vial: 2000 IU moroctocog alfa (approx.
1 viala: 2.000 i.e. moroktokoga alfa (pribl.
1 vial: 2000 IU nonacog alfa (approx.
1 viala: 2.000 i.e. nonakoga alfa (pribl.
1 vial: 2000 IU nonacog gamma, approx.
1 viala: 2000 i.e. nonakoga gama, pribl.
1 vial: 2000 IU octocog alfa (400 IU/mL after reconstitution).
1 hettuglas: 2000 a.e. októkóg alfa (400 a.e./ml eftir blöndun).
1 vial: 2000 IU octocog alfa (400 IU/ml after reconstitution).
1 viala vsebuje 2000 i.e. oktokoga alfa (po rekonstituciji 400 i.e./ml).